trial

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

NCTId NCT02918370
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 75 (actual)
Sponsored by University of Texas Southwestern Medical Center
Primary completion 2023-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
75 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2016-11
Primary completion
2023-06-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Aripiprazole

Sponsors

University of Texas Southwestern Medical CenterLead Sponsor

Sites

1 total
Dallas, United States

Linked catalysts

1
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder — primary completion2023-06-30

Facts & assertions

4 sourced
Enrollment
75
Phase
PHASE3
Primary Completion Date
2023-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
lead_sponsor
University of Texas Southwestern Medical Center
company
indication
Bipolar Disorder
indication
Alcohol Abuse
indication
Psychotic Disorders
indication